New study finds triple-negative breast cancer tumors with an …
WEBApr 25, 2024 · A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates even when not treated with chemotherapy.
Breast Cancer Drug Trial Results in ‘Unheard-Of’ Survival
WEBJun 7, 2022 · The clinical trial, sponsored by the pharmaceutical companies Daiichi Sankyo and AstraZeneca and led by Dr. Shanu Modi of Memorial Sloan Kettering Cancer Center, involved 557 patients with...
What's New in Breast Cancer - Susan G. Komen®
WEBLearn about new breast cancer treatment breakthroughs and recent developments in research that are fueling new ways to assess risk, prevent, detect and diagnose breast cancer.
Estrogen a more powerful breast cancer culprit than we realized
WEBMay 17, 2023 · A Harvard Medical School study shows the sex hormone estrogen — thus far thought to be only a fuel for breast cancer growth — can directly cause tumor-driving genomic rearrangements.
Breast Cancer News - ScienceDaily
WEB6 days ago · Breast cancer research including information on breast cancer symptoms, prevention strategies, screening techniques, and new breast cancer treatments.
New study finds triple-negative breast cancer tumors with an …
WEBApr 2, 2024 · New research suggests that people who have early-stage triple-negative breast cancer and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates.
Experimental immunotherapy targets metastatic breast cancer
WEBFeb 1, 2022 · Many people with metastatic breast cancer can mount an immune reaction against their tumors, the study found, a prerequisite for this type of immunotherapy, which relies on what are called tumor-infiltrating lymphocytes (TILs).
Breast Cancer News
WEBOur coverage of trending topics in breast cancer medicine, treatment, and screening, plus the latest on living with breast cancer.
Pembrolizumab for Advanced Triple-Negative Breast Cancer
WEBAug 9, 2022 · In the KEYNOTE-355 trial, 847 patients with advanced (unresectable, locally advanced, or metastatic) triple-negative breast cancer were randomly assigned to receive chemotherapy plus placebo or chemotherapy plus pembrolizumab.
Breast Cancer May Spread by Recruiting Nearby Sensory Nerves
WEB2 days ago · A new study shows how cells in breast tumors (1) recruit nearby nerves to (2) move into the tumors and (3) help the cancer spread to other parts of the body. The body is packed with sensory nerves that pass sensations like touch, pain, and temperature to the nervous system. Such nerves are tangled through tissues in every organ and many tumors.